Question 1

How many shares of PCVX does BlackRock, Inc. own?

Accepted Answer

As of 2026-Q2, BlackRock, Inc. holds 12.1M shares of PCVX (VAXCYTE INC).

Question 2

What is BlackRock, Inc.'s PCVX position worth?

Accepted Answer

As of 2026-Q2, BlackRock, Inc.'s PCVX position is worth $701.5M.

Question 3

Is BlackRock, Inc. buying or selling PCVX?

Accepted Answer

In 2026-Q2, BlackRock, Inc. increased their PCVX position (+10.0% change in shares).

Question 4

When did BlackRock, Inc. first buy PCVX?

Accepted Answer

Based on available 13F filings, BlackRock, Inc. first reported a position in PCVX in 2024-Q3. They have held the position across 8 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	12.1M	+10.0%	$701.5M	0.0%	$58.13	35
2026-Q1	Increased	11M	+7.1%	$637.6M	0.0%	$59.82	34
2025-Q4	Increased	10.2M	+2.9%	$472.8M	0.0%	$45.41	32
2025-Q3	Decreased	10M	-6.5%	$358.6M	0.0%	$34.65	0
2025-Q2	Increased	10.6M	+0.6%	$346M	0.0%	$32.58	31
2025-Q1	Decreased	10.6M	-4.7%	$399.5M	0.0%	$69.46	0
2024-Q4	Increased	11.1M	+4.1%	$909.1M	0.0%	$81.86	33
2024-Q3	First report	10.7M	-	$1.2B	0.0%	$114.27	0

PCVX8 quarters

PCVX
8 quarters